Hydroxydecanoate is enhanced in obesity-associated IR and type 2 diabetes (Al-Sulaiti et al., 2019); we, similarly, observed an increase in this metabolite in iNOS−/− mice and a reduction with vancomycin intervention. This evidence concerns the gene NOS2 and type 2 diabetes mellitus.